利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

51024 条记录 (耗时 0.058 秒)

    Drifting kart
    1.
    外观设计
    Drifting kart 有权

    公开(公告)号：USD1048951S1

    公开(公告)日：2024-10-29

    申请号：US29835940

    申请日：2022-04-22

    申请人： RAZOR USA LLC

    设计人： Robert (Wei-Pin) Chen

    摘要： FIG. 1 is a top, rear, and right side perspective view of a drifting kart embodying my new design;
    FIG. 2 is a top, front, and left side perspective view thereof;
    FIG. 3 is a front elevation view thereof;
    FIG. 4 is a rear elevation view thereof;
    FIG. 5 is a right side elevation view thereof;
    FIG. 6 is a left side elevation view thereof; and,
    FIG. 7 is a top plan view thereof.
    Broken lines are used to illustrate features of the drifting kart which form no part of the claimed design.

    Curable composition, cured product, and compound
    4.
    发明授权
    Curable composition, cured product, and compound 有权

    公开(公告)号：US12129335B2

    公开(公告)日：2024-10-29

    申请号：US17457107

    申请日：2021-12-01

    申请人： TOKYO OHKA KOGYO CO., LTD.

    发明人： Ryutaro Sugawara

    IPC分类号： C08G61/12 ,  C07D251/70

    CPC分类号： C08G61/122 ,  C07D251/70

    摘要： A curable composition that gives a cured product exhibiting a high refractive index and a surface without defects such as roughness or cracks, a cured product of the composition, and a compound that may be blended to the composition. In a curable composition including a triazine compound having three aromatic-ring-containing groups each bonded to the triazine ring via an amino group, an aromatic-ring-containing group having a specific structure having a radically polymerizable group-containing group or a cationically polymerizable group-containing group is used as at least one of the three aromatic-ring-containing groups bonded to the triazine ring in the triazine compound mentioned above.

    Enteric aerobization therapy
    8.
    发明授权
    Enteric aerobization therapy 有权

    公开(公告)号：US12128079B2

    公开(公告)日：2024-10-29

    申请号：US18109718

    申请日：2023-02-14

    申请人： LPOXY THERAPEUTICS, INC.

    发明人： Larry D. Sutton

    IPC分类号： A61K31/327 ,  A61K9/28 ,  A61K9/48 ,  A61K9/50 ,  A61K35/742 ,  A61K35/748 ,  A61K36/064 ,  A61K38/44 ,  A61P31/04

    CPC分类号： A61K36/064 ,  A61K9/28 ,  A61K9/4825 ,  A61K9/5042 ,  A61K31/327 ,  A61K35/742 ,  A61K35/748 ,  A61K38/44 ,  A61P31/04

    摘要： Agents, kits, and methods that utilize oxygenation to prevent and/or treat intestinal inflammation and/or infections caused by anaerobic microorganisms are provided. In several embodiments, the formulations are provided as a capsule within a capsule in order to separate an oxygen prodrug from a catalyst until the formulation is at a target site within the intestine. In several embodiments, the catalyst is provided in an excess of the oxygen prodrug. In several embodiments, the prodrug is within an inner capsule or coating and a biological material comprising a catalyst (e.g., yeast, spirulina, chlorella, etc.) surrounds the encapsulated prodrug and the biological material is within a capsule or coating. The agents, kits, and methods can be utilized to prevent and/or treat anaerobic bacterial infections of the intestinal lumen by enteric aerobization therapy.